Physician profile
Melissa Covington
NPI 1851457394
$1,386.06
in general payments reported to CMS, 2019-2025
16 companies · $423 in 2025
The $423 reported for 2025 was less than what a typical Pain Medicine (Anesthesiology) provider received nationally (typical 2025 total: $458).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2020: $31.87 · 2021: $450 · 2022: $187 · 2023: $140 · 2024: $154 · 2025: $423.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $717.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $717.35 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Boston Scientific Corporation | $346.31 | 2021-2025 | Intracept |
| Nevro Corp. | $323.95 | 2020-2024 | Senza |
| Abbott Laboratories | $159.43 | 2022-2023 | Proclaim |
| Relievant Medsystems, INC. | $110.86 | 2021 | |
| Globus Medical, INC. | $67.11 | 2025 | Senza |
| Vertex Pharmaceuticals Incorporated | $60.88 | 2025 | |
| Abbvie INC. | $54.39 | 2025 | |
| Medtronic, INC. | $50.17 | 2023-2025 | Inceptiv, Vanta Adaptivestim |
| Avanos Medical | $48.52 | 2024-2025 | Generator |
| Nalu Medical, INC. | $39.08 | 2022 | |
| Stemline Therapeutics INC. | $22.77 | 2024 | Orserdu |
| Astellas Pharma US INC | $22.27 | 2025 | Veozah |
| Blueprint Medicines Corporation | $22.05 | 2024 | Ayvakit |
| Astrazeneca Pharmaceuticals LP | $21.58 | 2025 | Enhertu |
| Tactile Systems Technology INC | $19.00 | 2025 | Nimbl, Flexitouch Plus |
Show all 16 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Incyte Corporation | $17.69 | 2024 | Pemazyre, Monjuvi |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Melissa Covington listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.